Sustained Delivery of SARS-CoV-2 RBD Subunit Vaccine Using a High Affinity Injectable Hydrogel Scaffold.

Authors:
Chen J; Wang B; Caserto JS; Shariati K; Cao P and 3 more

Journal:
Adv Healthc Mater

Publication Year: 2021

DOI:
10.1002/adhm.202101714

PMCID:
PMC8652948

PMID:
34755476

Journal Information

Full Title: Adv Healthc Mater

Abbreviation: Adv Healthc Mater

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biomedical Engineering

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest The authors declare no conflict of interest."

Evidence found in paper:

"J.C. and B.W. contributed equally to this work. This work was partially supported by Cornell COVID‐19 seed grant (B.W.) and the Hartwell Foundation (M.M.). This work made use of the Cornell Center for Materials Research Shared Facilities which are supported through the NSF MRSEC program (DMR‐1719875). Cornell Flow Cytometry Facility is thanked for access to FACSymphony A3."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025